Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Rakesh Jhunjhunwala,...

    Rakesh Jhunjhunwala, Premji vie to buy Star Health Insurance

    Written by Ruby Khatun Khatun Published On 2018-01-21T09:23:09+05:30  |  Updated On 21 Jan 2018 9:23 AM IST
    Rakesh Jhunjhunwala, Premji vie to buy Star Health Insurance

    CHENNAI: Indian giants Rakesh Jhunjhunwala and Azim Premji seem to in the race to buy Star Health, according to recent media reports


    Star Health and Allied Insurance is the first stand-alone health insurance company in the country carrying a price tag of $1 billion and Jhunjhunwala's RARE Enterprises has made a surprise bid for it states a report in TOI.


    The sale of the firm has been backed by all the investors of the Star Health that are ICICI Venture, Sequoia Capital, Tata Capital, Alpha TC Holdings, Apis Partners, Oman Insurance Company and ETA Star of Dubai.

    The other investors who have bid as the transaction has entered the last leg include Kedaara Capital, WestBridge, Temasek and Prudential and strategic investors including ICICI Lombard and HDFC General Insurance.


    Investment banking firm Kotak is managing the sale and the deal is expected to complete over the next couple of months.


    V Jagannathan, former CMD of United India is the man behind the firm who has driven the company to become one of the profitable insurers in the health space.


    Shareholders feel that since there are a number of health insurance companies opting to go public, it is the right time to sell the firm.


    According to TOI, there are two possibilities. First, bring in a financial investor who will provide an exit for all other shareholders in the company and get the company moving along with Jagannathan and management team at the helm. The second is a sale to a strategic investor. "The second option is unlikely as the management feels that the financial investor will help retain the Star Health brand," sources told the daily .

    Alpha TC HoldingsApis PartnersAzim PremjibuyHDFC General InsuranceICICI LombardICICI ventureKedaara CapitalKotakRakesh JhunjhunwalaRARE EnterprisesSequoia CapitalStar HealthStar Health and Allied insuranceStar health insuranceTata CapitalV Jagannathan
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok